Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets
Autor: | Aikaterini F. Giannopoulou, Dimitrios J. Stravopodis, Gerassimos E. Voutsinas, Athanasios Anagnostopoulos, Athanassios D. Velentzas, Eumorphia G. Konstantakou, Ourania A. Konstandi, Zoi I. Litou, Ema Anastasiadou, George Th. Tsangaris |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Melanomas Proteomics Skin Neoplasms Proteome Fibroblast Growth Factor Physiology Carcinogenesis Proteomes lcsh:Medicine Mice SCID medicine.disease_cause Biochemistry Database and Informatics Methods Endocrinology Cell Signaling Tandem Mass Spectrometry Medicine and Health Sciences Protein Interaction Maps lcsh:Science Melanoma Cultured Tumor Cells Multidisciplinary Middle Aged Microphthalmia-associated transcription factor 3. Good health Neoplasm Proteins Oncology Melanoma Cells Female Biological Cultures Signal Transduction Research Article Proto-Oncogene Proteins B-raf Bioinformatics Biology Research and Analysis Methods 03 medical and health sciences Paracrine signalling Genetic Heterogeneity Cancer stem cell Ammonia Cell Line Tumor Growth Factors medicine Animals Humans KEGG Melanins Oncogenic Signaling Microphthalmia-Associated Transcription Factor Endocrine Physiology lcsh:R Cancers and Neoplasms Biology and Life Sciences Proteins Cell Biology Cell Cultures medicine.disease 030104 developmental biology 14-3-3 Proteins Drug Resistance Neoplasm Cutaneous melanoma Cancer research lcsh:Q Propionates Neoplasm Transplantation Chromatography Liquid |
Zdroj: | PLoS ONE PLoS ONE, Vol 12, Iss 2, p e0171512 (2017) |
ISSN: | 1932-6203 |
Popis: | Cutaneous melanoma is a malignant tumor of skin melanocytes that are pigment-producing cells located in the basal layer (stratum basale) of epidermis. Accumulation of genetic mutations within their oncogenes or tumor-suppressor genes compels melanocytes to aberrant proliferation and spread to distant organs of the body, thereby resulting in severe and/or lethal malignancy. Metastatic melanoma's heavy mutational load, molecular heterogeneity and resistance to therapy necessitate the development of novel biomarkers and drug-based protocols that target key proteins involved in perpetuation of the disease. To this direction, we have herein employed a nano liquid chromatography-tandem mass spectrometry (nLC-MS/MS) proteomics technology to profile the deep-proteome landscape of WM-266-4 human metastatic melanoma cells. Our advanced melanoma-specific catalogue proved to contain 6,681 unique proteins, which likely constitute the hitherto largest single cell-line-derived proteomic collection of the disease. Through engagement of UNIPROT, DAVID, KEGG, PANTHER, INTACT, CYTOSCAPE, dbEMT and GAD bioinformatics resources, WM-266-4 melanoma proteins were categorized according to their sub-cellular compartmentalization, function and tumorigenicity, and successfully reassembled in molecular networks and interactomes. The obtained data dictate the presence of plastically inter-converted sub-populations of non-cancer and cancer stem cells, and also indicate the oncoproteomic resemblance of melanoma to glioma and lung cancer. Intriguingly, WM-266-4 cells seem to be subjected to both epithelial-to-mesenchymal (EMT) and mesenchymal-to-epithelial (MET) programs, with 1433G and ADT3 proteins being identified in the EMT/MET molecular interface. Oncogenic addiction of WM-266-4 cells to autocrine/paracrine signaling of IL17-, DLL3-, FGF(2/13)- and OSTP-dependent sub-routines suggests their critical contribution to the metastatic melanoma chemotherapeutic refractoriness. Interestingly, the 1433G family member that is shared between the BRAF- and EMT/MET-specific interactomes likely emerges as a novel and promising druggable target for the malignancy. Derailed proliferation and metastatic capacity of WM-266-4 cells could also derive from their metabolic addiction to pathways associated with glutamate/ammonia, propanoate and sulfur homeostasis, whose successful targeting may prove beneficial for advanced melanoma-affected patients. |
Databáze: | OpenAIRE |
Externí odkaz: |